A faster-acting mealtime insulin manufactured by Novo Nordisk is now approved and available in Canada. Novo Nordisk Canada Inc. announced that Fiasp (insulin aspart), a faster-acting mealtime insulin, is now approved and available in Canada. Fiasp is an innovative formulation of insulin aspart that more closely matches the natural physiological insulin response of a person without [...]
Medtronic plc, the global leader in medical technology, and Fitbit, the leader in the connected health and fitness market, announced a partnership to integrate health and activity tracking for patients living with diabetes and their physicians and care teams. The iPro™2 myLog mobile app will allow patients to see their glucose levels and physical activity [...]
Insulog, a device that connects with all major disposable insulin pen brands to display most recent injection data, paired with its app to display entire injection history in order to better manage diabetes, is today announcing the unveiling of its smart, connected insulin tracker. The device will soon be made available via Indiegogo, to bring [...]
At the meeting of Association for the Study of Diabetes (EASD) in Stockholm, Sweden, Sanofi-aventis announced the world’s first attachment to iPhone and iPod that is a standalone medical device. The plug-in iBGStar was developed by Sanofi-aventis and AgaMatrix. The iBGStar device not only relies on the iPhone to perform computational functions and display results, [...]